|
HangZhou ZhiJu Biotechnology Co., Ltd.
|
|
English name
|
Uridine 5’-diphosphate disodium salt
|
|
English aliases
|
5’-UDP,2Na; UDP- Na2;
Uridine 5-diphosphoric acid disodium salt;
|
|
CAS No.
|
27821-45-0
|
|
EINECS No.
|
248-678-9
|
|
Molecular formula
|
C9H12O12N2P2Na2
|
|
Molecular weight
|
448.12
|
|
Structural formula
|
|
|
Physical properties
|
This product is a white powder; freely soluble in water, insoluble in ethanol.
Under the condition of PH2.0,A250/A260 =0.70～0.80; A280/A260 =0.33～0.43; λmax=262 nm±1nm.
|
|
Purity（HPLC）
|
≥98%
|
|
Usage
|
This product belongs to the nucleotide products，and can be used as biochemical reagent and intermediate for the production nucleotide drugs.
|
|
Packing size
|
5kg/bag
|
|
Storage
|
Keep dry and away from light, sealed storage in - 20 ℃
|
|
Send Inquiry
|
|
Hangzhou Meiya Pharmaceutical Co., Ltd.
|
Appearance:White powder
pd_productuse:It can be used as an intermediate and biochemical reagent for the production of nucleotide drugs, and as an important raw material for the synthesis of other nucleotide derivatives (including poly u, polyc12u, poly a ∶ u, u2p4, oligonucleotides, etc.).
Name：Uridine 5’-diphosphate disodium salt
Aliases：UDP-Na2；5’-UDP,2Na
CAS No.27821-45-0
Molecular formula：C9H12O12N2P2Na2
Molecular weight：448.12
This advanced pharmaceutical intermediate applies developed enzymatic process, and it is produced in the GMP workshop which is under the quality management system of both China GMP and FSSC 22000. In addition, the QC lab is equipped with advanced HPLC, thin layer scanner, ultraviolet spectrophotometer, atomic flame spectrophotometer, gas chromatograph, etc. to strictly guarantee the quality monitor and management of each production step, which is in order to ensure the safety, stability and effectiveness of the product.
物理性质：
This product is a white powder; freely soluble in water, insoluble in ethanol.
Purity HPLC：≥95.0%
Contents dry basis：≥85.0%
Loss on drying：≤15.0%
storage：Preserve in tight，light-resistant containers, in a freezing place. |
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
